53 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company reported a narrower Q3 loss.
Tricida Q3 EPS $(0.79) Misses $(0.69) Estimate
Tricida (NASDAQ:TCDA) reported quarterly losses of $(0.79) per share which missed the analyst consensus estimate of $(0.69) by 14.49 percent. This is a 38.28 percent increase over losses of $(1.28) per share from the
Earnings Scheduled For November 8, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million.
Tricida Q2 EPS $(0.67) Beats $(0.84) Estimate
Tricida (NASDAQ:TCDA) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.84) by 20.24 percent. This is a 31.63 percent increase over losses of $(0.98) per share from the same
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 15)
Earnings Scheduled For May 6, 2021
Companies Reporting Before The Bell
• ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.